Metraipolis › archive › dc_36903e575baa

Patient-derived organoids guide personalized therapy for KRAS-mutant pancreatic cancer: synergistic MEK/mTOR inhibition and predictive chemotherapy responses — Europe PMC PMID:42220503

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42220503
DOI
10.3389/fimmu.2026.1760379
License (as archived)
solo-consultazione
Archived
2026-11-02T07:11:48.904Z
SHA-256 of the archived text
1e4f319988752cd7865281bda2e7d5e822da2f9ae59e09942e515953b67f6fc6
Stable URL of this page
https://metraipolis.com/documento/dc_36903e575baa

How to cite

Patient-derived organoids guide personalized therapy for KRAS-mutant pancreatic cancer: synergistic MEK/mTOR inhibition and predictive chemotherapy responses — Europe PMC PMID:42220503 — Europe PMC (en), https://europepmc.org/article/MED/42220503 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_36903e575baa (Metraipolis archive dc_36903e575baa, sha256 1e4f319988752cd7865281bda2e7d5e822da2f9ae59e09942e515953b67f6fc6)
BibTeX
@misc{dc36903e575baa,
  title = {Patient-derived organoids guide personalized therapy for KRAS-mutant pancreatic cancer: synergistic MEK/mTOR inhibition and predictive chemotherapy responses — Europe PMC PMID:42220503},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42220503},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_36903e575baa; sha256 1e4f319988752cd7865281bda2e7d5e822da2f9ae59e09942e515953b67f6fc6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42220503. Agents can read the archived copy with the MCP tool read_document.